findmyKOL
Clinical trialNCT00097344TerminatedPhase 3Interventional

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

SponsorIntarcia TherapeuticsEnrollment842Breast NeoplasmsNeoplasms, Hormone-Dependent
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

104 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria
  • Research Site

    Blagoevgrad, Bulgaria

  • Research Site

    Plovdiv, Bulgaria

  • Research Site

    Shumen, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Stara Zagora, Bulgaria

  • Research Site

    Varna, Bulgaria

Romania
  • Research Site

    Arad, Romania

  • Research Site

    Brasov, Romania

  • Research Site

    Bucharest, Romania

  • Research Site

    Bucharest, Romania

  • Research Site

    Cluj-Napoca, Romania

  • Research Site

    Oradea, Romania

  • Research Site

    Ploieşti, Romania

  • Research Site

    Timișoara, Romania

  • Research Site

    Târgu Mureş, Romania

Russia
  • Research Site

    Arkhangelsk, Russia

  • Research Site

    Astrakhan, Russia

  • Research Site

    Chelyabinsk, Russia

  • Research Site

    Engel's, Russia

  • Research Site

    Irkutsk, Russia

  • Research Site

    Kaliningrad, Russia

  • Research Site

    Kaluga, Russia

  • Research Site

    Kazan', Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Omsk, Russia

  • Research Site

    Orenburg, Russia

  • Research Site

    Oryol, Russia

  • Research Site

    Perm, Russia

  • Research Site

    Pyatigorsk, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Sochi, Russia

  • Research Site

    Syktyvkar, Russia

  • Research Site

    Tambov, Russia

  • Research Site

    Ufa, Russia

  • Research Site

    Ulyanovsk, Russia

64 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2004
Primary completion
Completion
31 Aug 2006
Last update posted
23 Aug 2007
Registered enrollment
842
Registry id
NCT00097344

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.